Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FQAAW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,083.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $2,083.08 for Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is executed under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award contract valued at $499.999 billion and extending through December 31, 2036.
The PPV-G GEN V represents a significant component of the Department of Defense's broader $30.3 billion pharmaceutical supply chain modernization initiative, designed to ensure consistent availability of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors under this acquisition strategy, with its established performance on numerous delivery orders across diverse therapeutic categories demonstrating capability to fulfill the specialized pharmaceutical requirements of the federal military medical system. No subcontractors were identified in connection with this award.
Quick answers
Who was awarded contract SPE2DB26FQAAW?
SPE2DB26FQAAW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FQAAW worth?
The government has obligated $2,083 on SPE2DB26FQAAW.
Is contract SPE2DB26FQAAW an order under another contract?
Yes. SPE2DB26FQAAW is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB26FQAAW competed?
The extent of competition for SPE2DB26FQAAW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award